Gilead Sciences posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst ...
Gilead Sciences posted fourth-quarter results that exceeded Wall Street estimates on Tuesday as its HIV drug sales rose 16% ...
The U.S. Food and Drug Administration on Tuesday approved Springworks Therapeutics' drug to treat a type of rare genetic ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from ...
House Bill 1724 would establish the Prescription Drug Affordability Board along with a stakeholder council to assist the ...
The Indiana Capital Chronicle sued the Indiana Department of Correction (IDOC) last week — a move we as an outlet don’t take ...
Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.
Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
A key part of California's Proposition 36 promised to direct people convicted of certain drug crimes to treatment. Counties are straining to make that happen without new funding.